Literature DB >> 6119898

Chemotherapeutic inhibitors of the enzymes of the de novo pyrimidine pathway.

T W Kensler, D A Cooney.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6119898     DOI: 10.1016/s1054-3589(08)60257-4

Source DB:  PubMed          Journal:  Adv Pharmacol Chemother        ISSN: 0065-3144


× No keyword cloud information.
  6 in total

Review 1.  Pyrimidine metabolism in schistosomes: A comparison with other parasites and the search for potential chemotherapeutic targets.

Authors:  Mahmoud H El Kouni
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2017-07-21       Impact factor: 2.231

2.  Pyrimidine biosynthesis in pathogens - Structures and analysis of dihydroorotases from Yersinia pestis and Vibrio cholerae.

Authors:  Joanna Lipowska; Charles Dylan Miks; Keehwan Kwon; Ludmilla Shuvalova; Heping Zheng; Krzysztof Lewiński; David R Cooper; Ivan G Shabalin; Wladek Minor
Journal:  Int J Biol Macromol       Date:  2019-06-15       Impact factor: 6.953

3.  Potentiation of antimetabolite antitumor activity in vivo by dipyridamole and amphotericin B.

Authors:  S S Cao; Y S Zhen
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Synthesis and in vitro evaluation of aspartate transcarbamoylase inhibitors.

Authors:  Laëtitia Coudray; Anne F Pennebaker; Jean-Luc Montchamp
Journal:  Bioorg Med Chem       Date:  2009-09-30       Impact factor: 3.641

5.  Identification of a trans-acting regulatory factor involved in the control of the pyrimidine pathway in E. coli.

Authors:  S F Nowlan; E R Kantrowitz
Journal:  Mol Gen Genet       Date:  1983

6.  Critical roles of CTP synthase N-terminal in cytoophidium assembly.

Authors:  Yong Huang; Jin-Jun Wang; Sanjay Ghosh; Ji-Long Liu
Journal:  Exp Cell Res       Date:  2017-03-22       Impact factor: 3.905

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.